Search research articles
Contact Us
Filters
Showing results (81-90 of 253) with videos related to
Page
of 26
Sort By:
Molecular Pharmacology
|
February 2, 2013
A receptor tyrosine kinase network composed of fibroblast growth factor receptors, epidermal growth factor receptor, v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, and hepatocyte growth factor receptor drives growth and survival of head and neck squamous carcinoma cell lines
Katherine R Singleton, Jihye Kim, Trista K Hinz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 11, 2010
Optimizing the detection of lung cancer patients harboring anaplastic lymphoma kinase (ALK) gene rearrangements potentially suitable for ALK inhibitor treatment
D Ross Camidge, Scott A Kono, Antonella Flacco, et al.
Proteomics. Clinical Applications
|
November 30, 2010
Quantitative proteomic analysis of ovarian cancer cells identified mitochondrial proteins associated with Paclitaxel resistance
Yuan Tian, Aik-Choon Tan, Xiaer Sun, et al.
Rheumatology (Oxford, England)
|
October 3, 2017
Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation
Giulio Cavalli, Marije Koenders, Vassili Kalabokis, et al.
Biology
|
February 25, 2022
DRPPM-EASY: A Web-Based Framework for Integrative Analysis of Multi-Omics Cancer Datasets
Alyssa Obermayer, Li Dong, Qianqian Hu, et al.
Nature Medicine
|
August 9, 2011
Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2
Traci R Lyons, Jenean O'Brien, Virginia F Borges, et al.
Cancer Research
|
September 12, 2015
Kinome RNAi Screens Reveal Synergistic Targeting of MTOR and FGFR1 Pathways for Treatment of Lung Cancer and HNSCC
Katherine R Singleton, Trista K Hinz, Emily K Kleczko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 5, 2010
Gene array and fluorescence in situ hybridization biomarkers of activity of saracatinib (AZD0530), a Src inhibitor, in a preclinical model of colorectal cancer
John J Arcaroli, Basel M Touban, Aik Choon Tan, et al.
Nature Reviews. Clinical Oncology
|
April 18, 2012
Patient-derived tumour xenografts as models for oncology drug development
John J Tentler, Aik Choon Tan, Colin D Weekes, et al.
Cancers
|
January 21, 2023
BCL2L11 Induction Mediates Sensitivity to Src and MEK1/2 Inhibition in Thyroid Cancer
Madison M Rose, Veronica L Espinoza, Katelyn J Hoff, et al.
Page
of 26
Search research articles
Search
Showing results (81-90 of 253) with videos related to
Sort By:
Page
of 26
Molecular Pharmacology
|
February 2, 2013
A receptor tyrosine kinase network composed of fibroblast growth factor receptors, epidermal growth factor receptor, v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, and hepatocyte growth factor receptor drives growth and survival of head and neck squamous carcinoma cell lines
Katherine R Singleton, Jihye Kim, Trista K Hinz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 11, 2010
Optimizing the detection of lung cancer patients harboring anaplastic lymphoma kinase (ALK) gene rearrangements potentially suitable for ALK inhibitor treatment
D Ross Camidge, Scott A Kono, Antonella Flacco, et al.
Proteomics. Clinical Applications
|
November 30, 2010
Quantitative proteomic analysis of ovarian cancer cells identified mitochondrial proteins associated with Paclitaxel resistance
Yuan Tian, Aik-Choon Tan, Xiaer Sun, et al.
Rheumatology (Oxford, England)
|
October 3, 2017
Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation
Giulio Cavalli, Marije Koenders, Vassili Kalabokis, et al.
Biology
|
February 25, 2022
DRPPM-EASY: A Web-Based Framework for Integrative Analysis of Multi-Omics Cancer Datasets
Alyssa Obermayer, Li Dong, Qianqian Hu, et al.
Nature Medicine
|
August 9, 2011
Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2
Traci R Lyons, Jenean O'Brien, Virginia F Borges, et al.
Cancer Research
|
September 12, 2015
Kinome RNAi Screens Reveal Synergistic Targeting of MTOR and FGFR1 Pathways for Treatment of Lung Cancer and HNSCC
Katherine R Singleton, Trista K Hinz, Emily K Kleczko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 5, 2010
Gene array and fluorescence in situ hybridization biomarkers of activity of saracatinib (AZD0530), a Src inhibitor, in a preclinical model of colorectal cancer
John J Arcaroli, Basel M Touban, Aik Choon Tan, et al.
Nature Reviews. Clinical Oncology
|
April 18, 2012
Patient-derived tumour xenografts as models for oncology drug development
John J Tentler, Aik Choon Tan, Colin D Weekes, et al.
Cancers
|
January 21, 2023
BCL2L11 Induction Mediates Sensitivity to Src and MEK1/2 Inhibition in Thyroid Cancer
Madison M Rose, Veronica L Espinoza, Katelyn J Hoff, et al.
Page
of 26